NVO Stock Latest News

Veru pact with Novo ‘significant event,’ says Canaccord

PremiumThe Fly

2d ago

Veru announces clinical supply agreement with Novo Nordisk

VERU

PremiumThe Fly

2d ago

Novo Nordisk Expands Obesity and Diabetes Pipeline With New Phase 1 Trial of NNC0497-0040

VERU

PremiumCompany Announcements

2d ago

Novo Nordisk Expands Obesity Pipeline With New First‑in‑Human Trial for NNC0113-5840

PremiumCompany Announcements

2d ago

PremiumMarket NewsASML Stock Crushes European Records as JPMorgan Analyst Warns Investors Are “Behind the Curve”

3d ago

SAP

Moderately bullish activity in Novo Nordisk with shares down 2.99%

The Fly

Moderately bullish activity in Novo Nordisk with shares down 2.99%

5d ago

Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)

TipRanks Newswire

Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)

5d ago

Novo Nordisk Details Progress of 2026 Share Buyback Programme

ARWR

PremiumCompany Announcements

5d ago

Cboe data suggests bullish flow in Novo Nordisk with shareslittle changed

PremiumThe Fly

8d ago

Novo Nordisk’s CagriSema Trial Puts Next-Generation Obesity Strategy in Focus

PremiumCompany Announcements

8d ago

Eli Lilly Stock (LLY) Jumps 5% as CVS Health Covers Its Weight-Loss Drugs

PremiumMarket News

9d ago

CVS

PremiumThe FlyCboe data shows mixed options sentiment in Novo Nordisk with shares up 1.46%

10d ago

Eli Lilly Stock (LLY) Gets a Price Target Boost as Weight-Loss Drug Sales Accelerate

Market News

Eli Lilly Stock (LLY) Gets a Price Target Boost as Weight-Loss Drug Sales Accelerate

10d ago

BAC

Novo Nordisk to showcase new data from its cardiometabolic portfolio at ADA

The Fly

Novo Nordisk to showcase new data from its cardiometabolic portfolio at ADA

10d ago

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

PremiumCompany Announcements

10d ago

Novo Nordisk Wins CHMP Backing for High-Dose Wegovy Single-Dose Pen in EU

PremiumCompany Announcements

15d ago

Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial

PremiumCompany Announcements

15d ago

Novo Nordisk’s AMAZE 4 Trial Targets Obesity and Sleep Apnea for Next Growth Leg

PremiumCompany Announcements

15d ago

PremiumCompany AnnouncementsNovo Nordisk Wins EMA Panel Backing for First Oral Wegovy Obesity Pill in EU

15d ago

Studies suggest Ozempic, Mounjaro may slow tumor progression, WSJ reports

The Fly

Studies suggest Ozempic, Mounjaro may slow tumor progression, WSJ reports

15d ago

Mixed options sentiment in Novo Nordisk with shares down 2.12%

The Fly

Mixed options sentiment in Novo Nordisk with shares down 2.12%

16d ago